Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary nontransitional neoplasms of the bladder].

C Varo Solís1, M Soto Delgado, A Hens Pérez

  • 1Servicio de Urología, Hospital Universitario de Puerto Real, Cádiz.

Actas Urologicas Espanolas
|September 17, 1999
PubMed
Summary

Primitive bladder tumors are rare, with non-transitional types comprising only 1.98% of cases. Malignant non-transitional bladder tumors show aggressive behavior and poor survival rates, necessitating further research into effective treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results.

Cancer medicine·2025
Same author

Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Non-metastatic castration-resistant prostate cancer: management recommendations.

Actas urologicas espanolas·2022
Same author

Development and assessment of an ex-vivo bench model aimed at laparoscopic ureteric reconstructive techniques.

Journal of pediatric urology·2021
Same author

Renal angiomyolipoma and tuberous sclerosis complex: long-term safety and efficacy outcomes of Everolimus therapy.

Actas urologicas espanolas·2021

Area of Science:

  • Urology
  • Oncology
  • Pathology

Context:

  • This study reviews primitive bladder tumors diagnosed between 1990 and 1998.
  • Non-transitional bladder tumors are rare, representing only 1.98% of all bladder neoplasms.
  • The study focuses on the characteristics, diagnosis, and treatment of these uncommon tumors.

Purpose:

  • To analyze the incidence, clinical presentation, and outcomes of non-transitional primitive bladder tumors.
  • To evaluate diagnostic and therapeutic approaches for these rare bladder neoplasms.
  • To highlight the aggressive nature and poor prognosis of malignant non-transitional bladder tumors.

Summary:

  • Out of 703 bladder neoplasms, 14 were non-transitional primitive tumors (11 malignant, 3 benign).
  • Epidermoid carcinoma was the most common malignant type (9 cases).

Related Experiment Videos

  • Malignant tumors exhibited aggressive behavior, with only 3 of 11 patients surviving long-term.

    • Impact:

    • Provides insights into the clinical behavior and management challenges of rare bladder tumors.
    • Emphasizes the need for further research to improve treatment strategies and patient outcomes.
    • Contributes to the understanding of bladder cancer epidemiology and pathology.